Cardiomyocytic apoptosis limited by bradykinin via restoration of nitric oxide after cardioplegic arrest

Journal of Surgical Research

Volumn 163, Issue 1, 2010, Pages

  Yeh, Chi Hsiao ^a,b   Chen, Tzu Ping ^a   Wang, Yao Chang ^a   Lin, Yu Min ^b   Fang, Shu Wen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

apoptosis; bradykinin; cardioplegia; ischemia; nitric oxide

Indexed keywords

BRADYKININ; BRADYKININ ANTAGONIST; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; AORTA ROOT; APOPTOSIS; ARTICLE; ASCENDING AORTA; BLOOD LEVEL; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CRYSTALLOID; CYTOKINE PRODUCTION; HEART ARREST; HEART MUSCLE CELL; INFLAMMATION; ISCHEMIA; MALE; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; RABBIT; REPERFUSION; REPERFUSION INJURY; SUPPLEMENTATION; SURGICAL TECHNIQUE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; BRADYKININ; CARDIOPULMONARY BYPASS; CASPASE 3; HEART ARREST, INDUCED; IN SITU NICK-END LABELING; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; NF-KAPPA B; NITRIC OXIDE; PEROXIDASE; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-AKT; RABBITS; TROPONIN I; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 77955925354     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.04.005     Document Type: Article

References (24)

1. K.M. Taylor, W.H. Bain, and J.J. Morton The role of angiotensin II in the development of peripheral vasoconstriction during open-heart surgery Am Heart J 100 1980 935
2. D.T. Engelman, M. Watanabe, and R.M. Engelman Constitutive nitric oxide release is impaired after ischemia and reperfusion J Thorac Cardiovasc Surg 110 1995 1047
3. R.M. Palmer, D.S. Ashton, and S. Moncada Vascular endothelial cells synthesize nitric oxide from L-arginine Nature 333 1988 664
4. T.B. Andrási, P. Soós, and G. Bakos L-arginine protects the mesenteric vascular circulation against cardiopulmonary bypass-induced vascular dysfunction Surgery 134 2003 72
5. G. Valen The basic biology of apoptosis and its implications for cardiac function and viability Ann Thorac Surg 75 2003 S656
6. K. Kuwahara, Y. Saito, and I. Kishimoto Cardiotrophin-1 phosphorylates Akt and Bad, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes J Mol Cell Cardiol 32 2000 13854
7. C.H. Yeh, Y.M. Lin, and Y.C. Wu Nitric oxide attenuates cardiomyocytic apoptosis via diminished mitochondrial complex I up-regulation from cardiac ischemia-reperfusion injury under cardiopulmonary bypass J Thorac Cardiovasc Surg 128 2004 180
8. F.M. Ho, W.W. Lin, and B.C. Chen High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF- κB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway Cell Signal 18 2006 391
9. C.H. Yeh, T.P. Chen, and Y.C. Wu Inhibition of NFκB activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion J Surg Res 125 2005 109
10. M. Goto, Y. Liu, and X.M. Yang Role of bradykinin in protection of ischemic preconditioning in rabbit hearts Circ Res 77 1995 611
11. Y. Kono, S. Sawada, and T. Kawahara Bradykinin inhibits serum-depletion-induced apoptosis of human vascular endothelial cells by inducing nitric oxide via calcium ion kinetics J Cardiovasc Pharmacol 39 2002 251
12. C.H. Yeh, T.P. Chen, and C.H. Lee Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor-alpha but not gamma activators Shock 26 2006 262
13. B.C. Chen, C.C. Yu, and H.C. Lei Bradykinin B2 receptor mediates NF- κB activation and cyclooxygenase-2 expression via the Ras/Raf-1/ERK pathway in human airway epithelial cells J Immunol 173 2004 5219
14. U.M. Fischer, O. Klass, and U. Stock Cardioplegic arrest induces apoptosis signal-pathway in myocardial endothelial cells and cardiac myocytes Eur J Cardiothorac Surg 23 2003 984
15. C. Depre, L. Wang, and X. Sui H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart Circ Res 98 2006 280
16. C. Communal, M. Sumandea, and P. de Tombe Functional consequences of caspase activation in cardiac myocytes Proc Natl Acad Sci USA 99 2002 6252
17. J.M. Patel, J. Zhang, and E.R. Block Nitric oxide-induced inhibition of lung endothelial cell nitric oxide synthase via interaction with allosteric thiols: Role of thioredoxin in regulation of catalytic activity Am J Respir Cell Mol Biol 15 1996 410
18. R.M. Bell, and D.M. Yellon Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: The role of PI3K, Akt, and eNOS J Mol Cell Cardiol 35 2002 185
19. P. Massoudy, B.F. Becker, and E. Gerlach Bradykinin accounts for improved postischemic function and decreased glutathione release of guinea pig heart treated with the angiotensin-converting enzyme inhibitor ramiprilat J Cardiovasc Pharmacol 23 1994 632
20. W. Linz, G. Wiemer, and P. Gohlke Contribution of kinins to the cardiovascular action of angiotensin converting enzyme inhibitors Pharmacol Rev 47 1995 25
21. K. Kaiserova, X.-L. Tang, and S. Srivastava Role of nitric oxide in regulating aldose reductase activation in the ischemic heart J Biol Chem 283 2008 9101
22. F. Gao, E. Gao, and T.-L. Yue Nitric oxide mediates the anti-apoptotic effect of insulin in myocardial ischemia-reperfusion: The roles of PI3-Kinase, Akt, and endothelial nitric oxide synthase phosphorylation Circulation 105 2002 1497
23. M.O. Hengartner The biochemistry of apoptosis Nature 407 2000 770
24. S. Kharbandra, P. Pandey, and L. Schofield Role of Bcl-xL as an inhibitor of cytosolic cytochrome c accumulation in DNA damage-induced apoptosis Proc Natl Acad Sci USA 94 1997 6939